Co-sponsorships To Bring Faster FDA Review, Inspection To New Technology
This article was originally published in The Gray Sheet
A May 22-25 course to instruct FDA scientific reviewers and field investigators on nucleic acid amplification testing (NAT) technology is one of several FDA/industry co-sponsorship activities planned for upcoming months.
You may also be interested in...
Roche Molecular Systems intends to submit product licensing applications (PLA's) for both minipool and individual donation nucleic acid test (NAT) assays for HCV and HIV in the first quarter of 2000, James Gallarda, PhD, the firm's blood screening program director, said at a Center for Biologics Evaluation and Research-sponsored workshop on the implementation of nucleic acid testing Dec. 14 in Bethesda, Maryland.
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.